Mark Smith, Finch Therapeutics CEO
April 19, 2022 10:30 AM EDT
People

Bear mar­ket shows no signs of abat­ing, claim­ing Finch Ther­a­peu­tics as the lat­est lay­off vic­tim

Max Gelman

Senior Editor

Much ink has been spilled over the con­tin­u­ing wave of lay­offs hit­ting the biotech in­dus­try, and that doesn’t look to be stop­ping any­time soon. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times